1. Home
  2. NWGL vs ENLV Comparison

NWGL vs ENLV Comparison

Compare NWGL & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWGL
  • ENLV
  • Stock Information
  • Founded
  • NWGL 2008
  • ENLV 2005
  • Country
  • NWGL Macau
  • ENLV Israel
  • Employees
  • NWGL N/A
  • ENLV N/A
  • Industry
  • NWGL
  • ENLV Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWGL
  • ENLV Health Care
  • Exchange
  • NWGL Nasdaq
  • ENLV Nasdaq
  • Market Cap
  • NWGL 26.2M
  • ENLV 23.7M
  • IPO Year
  • NWGL 2023
  • ENLV 1995
  • Fundamental
  • Price
  • NWGL $1.03
  • ENLV $1.06
  • Analyst Decision
  • NWGL
  • ENLV Strong Buy
  • Analyst Count
  • NWGL 0
  • ENLV 2
  • Target Price
  • NWGL N/A
  • ENLV $10.00
  • AVG Volume (30 Days)
  • NWGL 32.5K
  • ENLV 1.2M
  • Earning Date
  • NWGL 05-01-2025
  • ENLV 08-29-2025
  • Dividend Yield
  • NWGL N/A
  • ENLV N/A
  • EPS Growth
  • NWGL N/A
  • ENLV N/A
  • EPS
  • NWGL N/A
  • ENLV N/A
  • Revenue
  • NWGL $21,539,347.00
  • ENLV N/A
  • Revenue This Year
  • NWGL N/A
  • ENLV N/A
  • Revenue Next Year
  • NWGL N/A
  • ENLV N/A
  • P/E Ratio
  • NWGL N/A
  • ENLV N/A
  • Revenue Growth
  • NWGL N/A
  • ENLV N/A
  • 52 Week Low
  • NWGL $0.91
  • ENLV $0.81
  • 52 Week High
  • NWGL $6.61
  • ENLV $2.10
  • Technical
  • Relative Strength Index (RSI)
  • NWGL 37.66
  • ENLV 40.57
  • Support Level
  • NWGL $1.30
  • ENLV $0.98
  • Resistance Level
  • NWGL $1.45
  • ENLV $1.13
  • Average True Range (ATR)
  • NWGL 0.13
  • ENLV 0.16
  • MACD
  • NWGL -0.01
  • ENLV -0.04
  • Stochastic Oscillator
  • NWGL 6.36
  • ENLV 7.14

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: